Innovations
PLANT-BASED SOLUTIONS TO ADDRESS THE COVID-19 PANDEMIC
Africa is highly vulnerable to the current COVID-19 pandemic. While several vaccine and antiviral candidates to prevent
COVID-19 infection are currently under development, they most likely will be expensive, difficult to transport
and distribute to remote areas and not available in…
Egg-based platform for design, development and manufacturing of COVID-19 countermeasures.
Avril Biopharma’s main focus is rapid development of diagnostic, vaccine and therapeutic products using bioinformatics to design these products and our AdCEV(TM) protein expression technology to produce them inexpensively in hen eggs.
We are using our platform to address the urgent public-…